Merck【MRK】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

109.50

買値

売値

出来高

8,577,587

107.90 日の範囲 109.915

99.14 52 週間の範囲 134.63

時価総額

277.562B

前日終値

109.40

始値

109.09

時刻

109.4875

最終取引時間

財務取引量

US$ 935,807,708

VWAP

109.0992

平均取引量 (3 か月)

9,643,339

発行済株式数

2,534,809,312

配当利回り

2.81%

PER

762.01

1 株当たり利益 (EPS)

0.14

歳入

60.12B

純利益

365M

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vacci... Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.merck.com

本社

West Trenton, New Jersey, USA

設立

Merck and Co Inc is listed in the Pharmaceutical Preparations sector of the ニューヨーク証券取引所 with ticker MRK. The last closing price for Merck was US$109.40. Over the last year, Merck shares have traded in a share price range of US$ 99.14 to US$ 134.63.

Merck currently has 2,534,809,312 shares in issue. The market capitalisation of Merck is US$277.31 billion. Merck has a price to earnings ratio (PE ratio) of 762.01.

全体の流れ

ベアリッシュ

ネットプレミアム

-99M

Calls / Puts

23.08%

買い / 売り

37.78%

OTM / ITM

8.47%

Sweeps比率

0.00%

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio

Merck Underscores Continued Commitment to Fighting Infectious Diseases with More than 40 Data Presentations Across Vaccines, Antibacterials and Antivirals, Including Respiratory Syncytial Virus...

Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Event-Free Survival (EFS) as Perioperative Treatment Regimen in Patients With Resected, Locally Advanced Head and Neck Squamous Cell Carcinoma

KEYNOTE-689 is the first Phase 3 trial to demonstrate statistically significant and clinically meaningful improvement in EFS in the intent-to-treat population in the neoadjuvant and adjuvant...

Merck to Present New Long-Term Data for Tulisokibart (MK-7240), an Investigational Anti-TL1A Monoclonal Antibody, in Inflammatory Bowel Disease at UEG Week 2024

Tulisokibart is now being evaluated in two Phase 3 studies in ulcerative colitis and Crohn’s disease 12-week data from the Phase 2 ARTEMIS-UC trial recently published in the New England Journal...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.35	-0.318616294948	109.85	110.98	107.81	8358382	109.31201525	CS
4	-6.05	-5.23582864561	115.55	119.38	107.81	9622569	113.95239943	CS
12	-15.8	-12.6097366321	125.3	128.73	107.81	9643339	115.48963634	CS
26	-17.05	-13.4729355986	126.55	134.63	107.81	8546320	121.62527608	CS
52	5.51	5.29858640254	103.99	134.63	99.14	8470592	118.26646151	CS
156	27.865	34.1336436577	81.635	134.63	71.5	9333750	100.9324824	CS
260	25.135	29.7931606709	84.365	134.63	65.25	9917716	91.47090084	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
TCSContainer Store Group Inc	US$ 16.775 (64.95%)	456.98k
WOLFWolfspeed Inc	US$ 11.48 (20.84%)	20.39M
CURVTorrid Holdings Inc	US$ 3.90 (16.07%)	873.1k
NRGVEnergy Vault Holdings Inc	US$ 1.10 (15.78%)	1.44M
AMPXAmprius Technologies Inc	US$ 1.33 (15.65%)	2.48M
SRFMSurf Air Mobility Inc	US$ 2.01 (-38.53%)	2.53M
EBFEnnis Inc	US$ 20.425 (-15.28%)	358.69k
TISITeam Inc	US$ 21.45 (-14.71%)	69.9k
CIACitizens Inc	US$ 4.74 (-9.02%)	271.11k
FLUTFlutter Entertainment PLC	US$ 219.50 (-8.78%)	5.71M
PLTRPalantir Technologies Inc	US$ 43.51 (-0.02%)	66.21M
UBERUber Technologies Inc	US$ 86.34 (10.81%)	57.29M
BACBank of America Corporation	US$ 41.95 (4.95%)	50.66M
NIONIO Inc	US$ 6.245 (0.40%)	42.9M
ALTMArcadium Lithium plc	US$ 5.56 (0.54%)	40.23M